Published trade mark details for 2618898
This information was published on 2026-01-15T04:18:18 for IP Right Filed Published.
| Field | Value |
| (210) | 2618898 (IR 1896655) |
| (220) |
12 Nov 2025
|
| (300) |
US, 08 Aug 2025, 99328453
|
| (500) |
The mark consists of an abstract image of a bird made out of a circle, teardrops, and a square to the left of the word terns.
|
| (511) (510) |
Class 5
Pharmaceutical preparations, namely, small-molecule drugs for the treatment of cancer, metabolic disorders, and endocrine disorders; pharmaceutical and biologic preparations for use in the treatment of oncology-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic preparations for use in the treatment of diabetes and obesity-related diseases and disorders; peptides for pharmaceutical purposes, namely, for the treatment of cancer, metabolic disorders, and endocrine disorders. Class 42 Pharmaceutical and biologic drug development services, namely, development of small-molecule drugs for use in humans; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of oncology-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of metabolic-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of endocrine-related diseases and disorders; pharmaceutical and biologic drug development services, namely, development of pharmaceutical and biologic preparations for the treatment of diabetes and obesity-related diseases and disorders; research and development services in the field of pharmaceutical and biologic preparations; research and development services in the field of oncology-related diseases and disorders; research and development services in the field of metabolic-related diseases and disorders; research and development services in the field of endocrine-related diseases and disorders; research and development services in the fields of diabetes and obesity-related diseases and disorders; research and development services in the field of peptide pharmaceutical preparations; providing medical and scientific research information in the field of small-molecule drugs; providing medical and scientific research information in the field of clinical trials and post-market trials; providing medical and scientific research information in the field of oncology, metabolic, endocrine, diabetes, and obesity-related diseases and disorders. |
| (540) |
|
| (550) | Figurative |
| (730) |
Terns Pharmaceuticals, Inc.
|
Find out more about publications on the About page.